标题
Risk of adverse COVID-19 outcomes for people living with HIV
作者
关键词
-
出版物
AIDS
Volume Publish Ahead of Print, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-02-27
DOI
10.1097/qad.0000000000002836
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hospitalized patients with COVID-19 and HIV: a case series
- (2020) Kate Childs et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19
- (2020) Noga Shalev et al. CLINICAL INFECTIOUS DISEASES
- COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients
- (2020) Georg Härter et al. INFECTION
- Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis
- (2020) Ya Gao et al. JOURNAL OF INFECTION
- Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
- (2020) Nathan Ford et al. Journal of the International AIDS Society
- Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
- (2020) Pilar Vizcarra et al. Lancet HIV
- HIV infection and COVID-19
- (2020) Nicolas Etienne et al. AIDS
- Factors associated with hospital admission for COVID-19 in HIV patients
- (2020) Antonio Di Biagio et al. AIDS
- Characteristics and outcomes of COVID-19 in patients with HIV
- (2020) Yousaf B. Hadi et al. AIDS
- The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries
- (2020) Nikkil Sudharsanan et al. ANNALS OF INTERNAL MEDICINE
- Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
- (2020) Julia del Amo et al. ANNALS OF INTERNAL MEDICINE
- Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City
- (2020) Keith Sigel et al. CLINICAL INFECTIOUS DISEASES
- Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review
- (2020) TJ Cooper et al. HIV MEDICINE
- SARS‐CoV‐2 infection in persons living with HIV: a single center prospective cohort
- (2020) Franco Maggiolo et al. JOURNAL OF MEDICAL VIROLOGY
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
- (2020) Geehan Suleyman et al. JAMA Network Open
- Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study
- (2020) Anna Maria Geretti et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa
- (2020) Andrew Boulle et al. CLINICAL INFECTIOUS DISEASES
- Outcomes Among HIV-Positive Patients Hospitalized With COVID-19
- (2020) Savannah Karmen-Tuohy et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
- (2020) Krishnan Bhaskaran et al. Lancet HIV
- An overview of tenofovir and renal disease for the HIV-treating clinician
- (2018) Willem D.F. Venter et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Pulmonary infections in HIV-infected patients: an update in the 21st century
- (2011) N. Benito et al. EUROPEAN RESPIRATORY JOURNAL
- Influenza Susceptibility, Severity, and Shedding in HIV-Infected Adults: A Review of the Literature
- (2010) A. N. Sheth et al. CLINICAL INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started